Where clinical depth
meets strategic clarity.

Leading AI strategy and innovation at one of the world’s most trusted medical imaging companies — a global leader in enterprise imaging across radiology, pathology, and orthopaedics. Responsible for translating emerging AI capabilities into clinical and commercial strategy across a global customer base. Instrumental in winning Sectra’s largest customer to date: Santé Québec — a province-wide enterprise PACS deployment covering the entire Quebec health system, running on Microsoft Azure, a scale of enterprise imaging not seen anywhere in the world. Working directly with Santé Québec physicians to lead research and clinical innovation for AI adoption at provincial scale.

A deliberate step into Silicon Valley-style company building — venture-backed, founder-led, moving at a speed that enterprise healthcare rarely tolerates. The experience of ramping up a business at startup velocity, making decisions with incomplete information, and operating under the scrutiny of investors and clinical customers simultaneously is a different discipline from enterprise leadership — and one that directly informs how Borealis Health advises founders navigating the same pressures. Tripled the addressable market through strategic repositioning. Worked directly alongside founders Albert Hsiao and John Axerio-Cilies and a world-class leadership team — an environment that sharpened thinking on what rigorous AI product development actually requires. Led a talented group of product managers and data scientists in expanding the clinical AI suite from its cardiac foundation into MSK, Neuro, and Oncology — bringing applications to market from a pipeline of 200+ in under 6 months. Assembled and led a clinical advisory board spanning multiple physician specialties. Designed a next-generation AI-first UX that improved radiologist productivity 2–3×. Arterys holds a unique place in the history of medical AI: the company launched the first-ever commercially approved pixel-level AI SaMD — the foundational milestone for an entire category. A decade of cloud-native architecture before most vendors had even started the conversation. This was my first hands-on immersion in a truly cloud-native stack — and the sophistication of that architecture, including the ability to aggregate user and productivity insights at a scale no other vendor in the market has matched, remains the benchmark. It shaped how I think about what serious cloud-native health technology actually looks like versus what is simply marketed as such.

Led the strategic and cultural shift from departmental PACS positioning to enterprise health system strategy — reorienting product narrative, sales motion, and executive relationships toward the C-suite. Foundational leader for Stratus, a new cloud-native medical imaging platform built on Google Cloud — influenced the architecture and direction from the ground up. Led build-vs-buy evaluations that resulted in the acquisition of Nucleus.io, a cloud-native viewer technology stack. Commissioned a multi-year, 60-practice study across 30 IDNs and 30 independent practices that became the definitive clinical evidence and go-to-market foundation — and where the operating principle of trusting data over assumption was forged. Represented the company directly with health system and hospital leadership across the US: managing damaged relationships, rebuilding trust, and leading onsite commercial teams during strategic tender processes.

Rose from Product Manager to Senior Global Marketing Manager over 16 years, managing IMPAX — a $693M revenue PACS platform — across 70+ countries. Led R&D groups as large as 200 people. This is where thousands of hours were invested alongside physicians across specialties — getting inside their heads, understanding clinical workflow at the level of individual keystrokes and cognitive load, and translating that directly into product decisions with large R&D teams. Very few people in health IT have accumulated this depth of clinical proximity. It is the foundation that makes every subsequent role possible. Executed one of health IT’s most significant product turnarounds: stepped in after a year of failed leadership, a programme running 12 months over schedule with no end in sight, and a company that had missed revenues by €170M. Delivered the release. Led GTM strategy and won marquee accounts including Stanford Medicine, Mayo Clinic, and Northwestern Medicine.

First professional role in health tech, following co-op experience including clinical work at McMaster University Medical Centre in Hamilton. Mitra was a product of Silicon North — the Waterloo region's golden era of technology innovation, shaped by the University of Waterloo's engineering culture and a generation of builders who created world-class companies from Canadian soil. Growing up professionally in that environment — ambitious, technically rigorous, globally oriented — established a baseline for what serious technology companies look like. Mitra Imaging was ground zero for radiology's shift from film to digital — and where a deep education in healthcare interoperability began. Grew up professionally under the leadership of Eric L. Peterson (C.M., Order of Canada) and a team of people who went on to do remarkable things in health and beyond. That environment — intellectually rigorous, mission-driven, world-class — shaped everything that followed and remains the single most formative chapter of the career. Relocated to Eindhoven, Netherlands for a year to build and lead Mitra's European operations from the ground up — first real exposure to building and selling into global markets. This established an orientation that has defined every role since: building product for the world, not just the market where you happen to sit. A particular focus on the US market, where early adoption of healthcare innovation consistently happens first — making it the critical proving ground for any serious health technology strategy. Built foundational fluency in HL7, DICOM, and HIS-to-modality integration.